The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen
avobenzone, octinoxate, octisalate, titanium dioxide · AVOBENZONE 25 mg/mL; OCTINOXATE 30 mg/mL; OCTISALATE 30 mg/mL; TITANIUM DIOXIDE 12.5 mg/mL · Lotion · Topical · PureTek Corporation
NDC 59088-0568-05 · 56 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M020
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of avobenzone, octinoxate, octisalate, titanium dioxide (Lotion)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| PureTek Corporation | AVOBENZONE 25 mg/mL; OCTINOXATE 30 mg/mL; OCTISALATE 30 mg/mL; TITANIUM DIOXIDE 12.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen — NDC 59088-0568-05," retrieved September 3, 2026, https://drugdashboards.com/drug/59088056805.
Free to cite with attribution — see how the data is put together.